companydata.dkLEO PHARMA A/S: Financial statements 2017
CVR: 56759514
LEO PHARMA A/S (CVR 56759514) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 10,481,000,000 and a net result of DKK 1,381,000,000 compared with DKK 743,000,000 the year before. That is an increase of 42.4% compared with the year before. The profit margin was 13.2%. Equity amounted to DKK 8,277,000,000. The solvency ratio was 56.7%.
- Revenue
- 10,481,000,000 kr.
- Gross Profit
- 7,543,000,000 kr.
- Profit/Loss
- 1,381,000,000 kr.
- Equity
- 8,277,000,000 kr.
- Total Assets
- 14,593,000,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 10.5 mia. | 7.5 mia. | 1.4 mia. | 8.3 mia. | - |
| 2016 | 7.4 mia. | 2.7 mia. | 743 mio. | 25.2 mia. | 5170 |
| 2015 | 6.9 mia. | 2 mia. | 645 mio. | 25.3 mia. | 4813 |
| 2014 | 6.6 mia. | - | 1.5 mia. | 24.5 mia. | 4712 |
| 2013 | 5.8 mia. | - | 1.2 mia. | 23.1 mia. | 4733 |
Find more companies like LEO PHARMA A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
As of May 23, 2017, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of LEO PHARMA A/S.
As of May 23, 2017, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of LEO PHARMA A/S.
LEO PHARMA A/S has published its annual report for 2016. Revenue came to DKK 7,360,000,000, and the net result was DKK 743,000,000.
As of March 30, 2017, Cristina Patricia Lage has joined the board of directors of LEO PHARMA A/S.
As of March 30, 2017, Johannes Gerardus Joseph van de Winkel has joined the board of directors of LEO PHARMA A/S.
As of March 30, 2017, Jens Bo Olesen has left the board of directors of LEO PHARMA A/S.
About LEO PHARMA A/S
LEO PHARMA A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1962. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named LØVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB. The management consists of Philip Harald Eickhoff and Christophe Dominique Luc Charles Bourdon. The company is owned by LEO Holding A/S and Cidron Savanna 4 SARL. The company has 2,040 employees. In 2025, the company reported revenue of DKK 13,499,000,000 and a net result of DKK 2,489,000,000 compared with DKK -1,776,000,000 the year before. Equity amounted to DKK 5,262,000,000.